Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors
Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors |
|
https://doi.org/10.18632/oncotarget.27043
Litia A. Carvalho,
and Bakhos A. Tannous
|
| 4351-4353 |
PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?
PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one? |
|
https://doi.org/10.18632/oncotarget.27045
Cédric Rossi,
and Olivier Casasnovas
|
| 4354-4355 |
Differential gene expression and AKT targeting in triple negative breast cancer
Differential gene expression and AKT targeting in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.27026
Feng-Mao Lin,
Susan E. Yost,
Wei Wen,
Paul H. Frankel,
Daniel Schmolze,
Pei-Guo Chu,
Yate-Ching Yuan,
Zheng Liu,
John Yim,
Zhen Chen,
and Yuan Yuan
|
| 4356-4368 |
Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS)
Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) |
|
https://doi.org/10.18632/oncotarget.27028
Goro Kasuya,
Kazuki Terashima,
Kei Shibuya,
Shingo Toyama,
Daniel K. Ebner,
Hiroshi Tsuji,
Tomoaki Okimoto,
Tatsuya Ohno,
Yoshiyuki Shioyama,
Takashi Nakano,
Tadashi Kamada,
and the Japan Carbon-Ion Radiation Oncology Study Group
|
| 4369-4379 |
Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells
Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells |
|
https://doi.org/10.18632/oncotarget.27029
Elvin Peter Chizenga,
Rahul Chandran,
and Heidi Abrahamse
|
| 4380-4396 |
Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study
Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study |
|
https://doi.org/10.18632/oncotarget.27030
Dorte Schou Nørøxe,
Olga Østrup,
Christina Westmose Yde,
Lise Barlebo Ahlborn,
Finn Cilius Nielsen,
Signe Regner Michaelsen,
Vibeke Andrée Larsen,
Jane Skjøth-Rasmussen,
Jannick Brennum,
Petra Hamerlik,
Hans Skovgaard Poulsen,
and Ulrik Lassen
|
| 4397-4406 |
Dicer prevents genome instability in response to replication stress
Dicer prevents genome instability in response to replication stress |
|
https://doi.org/10.18632/oncotarget.27034
Michalis Fragkos,
Viviana Barra,
Tom Egger,
Benoit Bordignon,
Delphine Lemacon,
Valeria Naim,
and Arnaud Coquelle
|
| 4407-4423 |
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo |
|
https://doi.org/10.18632/oncotarget.27040
Elgilda Musi,
Gary K. Schwartz,
Jae Hyuk Yoo,
Shannon J. Odelberg,
Dean Y. Li,
Michael Y. Bonner,
Ponniah Selvakumar,
Shikha Rao,
Linda C. Gilbert,
Justin Elsey,
and Jack L. Arbiser
|
| 4424-4436 |
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer |
|
https://doi.org/10.18632/oncotarget.27055
Laris Achlaug,
Rive Sarfstein,
Karthik Nagaraj,
Lena Lapkina-Gendler,
Ilan Bruchim,
Manisha Dixit,
Zvi Laron,
Shoshana Yakar,
and Haim Werner
|
| 4437-4448 |
Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme
Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.27056
Yvonne Becker,
Sarah Förster,
Gerrit H. Gielen,
Ian Loke,
Morten Thaysen-Andersen,
Christine Laurini,
Kristin Wehrand,
Torsten Pietsch,
and Simone Diestel
|
| 4449-4465 |
Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines
Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines |
|
https://doi.org/10.18632/oncotarget.27063
Isabelle Doignon,
Olivier Fayol,
and Olivier Dellis
|
| 4466-4478 |
CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer
CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27065
Yang Zeng,
Binghao Li,
Tao Li,
Wei Liu,
Chongzhao Ran,
Richard T. Penson,
Mark C. Poznansky,
Yanan Du,
and Huabiao Chen
|
| 4479-4491 |
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease |
|
https://doi.org/10.18632/oncotarget.27037
Luigi Maiuri,
Valeria Raia,
Mauro Piacentini,
Antonella Tosco,
Valeria Rachela Villella,
and Guido Kroemer
|
| 4492-4500 |
Correction: Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease
Correction: Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease |
|
https://doi.org/10.18632/oncotarget.27049
Hongxing Li,
Bo Li,
Dongmei Zhu,
Hua Xie,
Chunxia Du,
Yankai Xia,
and Weibing Tang
|
| 4501-4502 |
Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation |
|
https://doi.org/10.18632/oncotarget.27066
Susanne V. Schmidt,
Stefanie Seibert,
Barbara Walch-Rückheim,
Benjamin Vicinus,
Eva-Maria Kamionka,
Jennifer Pahne-Zeppenfeld,
Erich-Franz Solomayer,
Yoo-Jin Kim,
Rainer M. Bohle,
and Sigrun Smola
|
| 4503-4504 |
Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency |
|
https://doi.org/10.18632/oncotarget.27073
Jayaraju Dheekollu,
Kimberly Malecka,
Andreas Wiedmer,
Henri-Jacques Delecluse,
Alan K.S. Chiang,
Dario C. Altieri,
Troy E. Messick,
and Paul M. Lieberman
|
| 4505-4506 |
